Clinical Trial Results:
Zur Frage des neuroleptikainduzierten metabolischen Syndroms.
Studie 2:
Fettverteilung und spezifische hormonelle Parameter. Vergleich zwischen auf
das metabolische Syndrom vulnerablen und nicht vulnerablenPatienten aus dem schizophrenen Formenkreis
Summary
|
|
EudraCT number |
2006-004036-71 |
Trial protocol |
AT |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
07 Jan 2021
|
First version publication date |
07 Jan 2021
|
Other versions |
|
Summary report(s) |
Statement_no patients included |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.